Dr. Kelly Huang to Obalon; Alisa Lask to Oversee Galderma’s Aesthetic & Corrective Business Unit

Thursday, September 07, 2017 | Personnel/Company News , Fillers & Injectables , Skin Care , Galderma


Former Galderma general manager Kelly Huang, Ph.D. is now Obalon’s Chief Operating Officer.

In this new role, Dr. Huang will be responsible for the key commercial functions of sales, marketing, operations, and quality assurance.

In related news, Alisa Lask is Galderma’s new Vice President and General Manager of the Aesthetic & Corrective Business Unit in the United States, effective September 1, 2017.

Alisa was previously Vice President of Marketing of the same business unit.

In her new role, Alisa will manage Galderma's broad portfolio of treatments -including Restylane® Refyne, Restylane®Defyne, Restylane® Silk, Restylane® Lyft with Lidocaine, Restylane® - L and Sculptra® Aesthetic.

"I am confident with Galderma's rich pipeline we will continue to bring solutions to the marketplace that transform category expectations, and I'm honored to lead a business unit poised to deliver a new chapter of aesthetic innovation," says Alisa in a news release.

Alisa worked at Allergan in global strategic marketing for facial aesthetics where she focused on new product planning in aesthetic innovation. Prior to that, she was Vice President of global strategic marketing at Zimmer Biomet. Additionally, Alisa spent 11 years at Eli Lilly specializing in marketing for women's health and neuroscience. She received an MBA from University of Michigan in Marketing and a Bachelor's degree from University of Miami, Oxford, Ohio in Marketing and Finance.

Next Story

Comments

You must be logged in to leave a comment.